US Patent Number

4284648

Publication Date

8-18-1981

Abstract

The invention relates to a novel method of administering propranolol, a known β-andrenergic blocking agent widely used in the treatment of angina pectoris, arrhythmias, hypertension and other cardiac conditions, and migraine. The invention further relates to novel dosage forms of propranolol which are adapted for nasal administration and which include solutions, suspensions, gels and ointments.

Assignees

University of Kentucky Research Foundation, Lexington, Ky.

Application Number

63,176

Filing Date

08/03/1979

Share

COinS